For the quarter ending 2025-09-30, UCLE has $2,537,709 in assets. $2,391,319 in debts.
| Balance Sheets | 2025-09-30 | 2025-03-31 | ||
|---|---|---|---|---|
| Cash | 75,907 | 68,489 | ||
| Prepaid expenses and other current assets | - | 0 | ||
| Accounts receivable, net | 129,945 | 60,985 | ||
| Note receivable | 51,735 | 41,916 | ||
| Inventories | 1,704,523 | 1,750,121 | ||
| Total current assets | 1,962,110 | 1,921,511 | ||
| Property and equipment, gross | 432,523 | 432,523 | ||
| Less accumulated depreciation | 431,639 | 430,919 | ||
| Property and equipment, net | 884 | 1,604 | ||
| Investments | 4,539 | 4,539 | ||
| Goodwill | 570,176 | 570,176 | ||
| Total assets | 2,537,709 | 2,497,830 | ||
| Accounts payable - related party | - | 0 | ||
| Accounts payable | 210,235 | 252,645 | ||
| Convertible notes payable, net of debt discount | - | 144,000 | ||
| Accrued liabilities | 1,116,925 | 1,111,480 | ||
| Accrued compensation officers | 13,000 | 13,000 | ||
| Customer deposit | 292,633 | 302,607 | ||
| Notes payable | 97,094 | 135,411 | ||
| Note payable to shareholder | 96,812 | 104,512 | ||
| Line of credit | 409,448 | 311,273 | ||
| Total current liabilities | 2,236,147 | 2,374,928 | ||
| Notes payable | 155,172 | 805,422 | ||
| Total long-term liabilities | 155,172 | 805,422 | ||
| Common shares to be issued (593,556 shares) | - | 87,362 | ||
| Total liabilities | 2,391,319 | 3,180,350 | ||
| Common stock, 0.0001 par value 100,000,000 shares authorized, 61,382,263 and 52,712,778 shares issued and outstanding | 6,139 | 5,893 | ||
| Common shares to be issued (4,009,716 shares) | 197,558 | - | ||
| Preferred stock, series a, 0.0001 par value, 10,000 shares authorized, 2,006 and -0-, issued and outstanding | 266 | 2,006,000 | ||
| Additional paid in capital | 20,408,521 | 17,526,009 | ||
| Accumulated deficit | -20,466,094 | -20,307,784 | ||
| Total shareholders equity | 146,390 | -682,520 | ||
| Total liabilities and shareholders equity | 2,537,709 | 2,497,830 | ||
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)